Skip to main content

Viking Global Investors LP's Form 4 filing

PROCEPT BioRobotics Corp (PRCT) · filed Sep 21, 2021

Accession no.
0001567619-21-017393
Filed
Sep 21, 2021, 4:27 PM ET
Trade date
Sep 17, 2021
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market purchases total $14.0M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Viking Global Investors LPCIK 000110380410% Owner
Halvorsen Ole AndreasCIK 000113300610% Owner
Ott David C.CIK 000162184210% Owner
Viking Global Opportunities Portfolio GP LLCCIK 000162947210% Owner
Viking Global Opportunities GP LLCCIK 000162947610% Owner
Viking Global Opportunities Illiquid Investments Sub-Master LPCIK 000162948210% Owner
Shabet Rose SharonCIK 000171139310% Owner
Dragsa 88 LLCCIK 000188334810% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 17, 2021Common StockCConversionAcquired+3,407,028–F5–3,715,170Indirect
Sep 17, 2021Common StockCConversionAcquired+678,985–F6–4,394,155Indirect
Sep 17, 2021Common StockCConversionAcquired+113,737–F7–4,507,892Indirect
Sep 17, 2021Common StockPPurchaseAcquired+400,000$35.00+$14,000,000400,000Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 17, 2021Common StockCConversionDisposed−3,407,028$0.00$00Indirect
Sep 17, 2021Common StockCConversionDisposed−678,985$0.00$00Indirect
Sep 17, 2021Common StockCConversionDisposed−113,737$0.00$00Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F5

The Series E Preferred Units were convertible into shares of Common Stock on a 1:1 basis, at the Reporting Person's election, without payment of further consideration, and automatically converted immediately prior to the closing of the initial public offering (the "Closing") of PROCEPT BioRobotics Corp (the "Issuer"). The shares had no expiration date.

Referenced by the price of 1 transaction in Table I.

F6

The Series F Preferred Units were convertible into shares of Common Stock on a 1:1 basis, at the Reporting Person's election, without payment of further consideration, and automatically converted immediately prior to the Closing. The shares had no expiration date.

Referenced by the price of 1 transaction in Table I.

F7

The Series G Preferred Units were convertible into shares of Common Stock on a 1:1 basis, at the Reporting Person's election, without payment of further consideration, and automatically converted immediately prior to the Closing. The shares had no expiration date.

Referenced by the price of 1 transaction in Table I.

Remarks

Scott M. Hendler is signing on behalf of Mr. Halvorsen, Mr. Ott and Ms. Shabet, each individually and as an Executive Committee Member of VIKING GLOBAL PARTNERS LLC, on behalf of VIKING GLOBAL INVESTORS LP (for itself and as manager of DRAGSA 88 LLC), and as an Executive Committee Member of VIKING GLOBAL OPPORTUNITIES GP LLC, on behalf of itself and VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC, and VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP, pursuant to authorization and designation letters dated February 9, 2021, which were filed with the Securities and Exchange Commission on June 7, 2021.

Read the full filing on SEC EDGAR (opens in a new tab)